U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula 3C6H11O7.Cr
Molecular Weight 637.4381
Optical Activity UNSPECIFIED
Defined Stereocenters 12 / 12
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of CHROMIUM GLUCONATE

SMILES

[Cr+3].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O

InChI

InChIKey=ANPGUZATXCGJJH-OPDGVEILSA-K
InChI=1S/3C6H12O7.Cr/c3*7-1-2(8)3(9)4(10)5(11)6(12)13;/h3*2-5,7-11H,1H2,(H,12,13);/q;;;+3/p-3/t3*2-,3-,4+,5-;/m111./s1

HIDE SMILES / InChI

Molecular Formula Cr
Molecular Weight 51.9961
Charge 3
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula C6H11O7
Molecular Weight 195.1473
Charge -1
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 4 / 4
E/Z Centers 0
Optical Activity UNSPECIFIED

Chromium sulfate(III) hexahydrate or chromium sulphate, a trivalent compound of chromium that was investigated as a toxic compound. Experiments on rodent have shown chromium sulfate produced severe and widespread effects in the nasal cavity, larynx, lungs, and mediastinal lymph node. Effects were characterized by the accumulation of foreign material, infiltration of alveolar macrophages, septal cell hyperplasia, and granulomatous and chronic inflammation. Besides, chromium sulphate exerted a disadvantageous effect on the skeleton, as it decreases bone density and resistance.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Preventing
CHROMIUM

Approved Use

Chromium 4 mcg/mL (Chromic Chloride Injection, USP) is indicated for use as a supplement to intravenous solutions given for total parenteral nutrition. Administration helps to maintain chromium serum levels and to prevent depletion of endogenous stores and subsequent deficiency symptoms.

Launch Date

2005
PubMed

PubMed

TitleDatePubMed
Cytokine induction in human epidermal keratinocytes exposed to contact irritants and its relation to chemical-induced inflammation in mouse skin.
1994 Jun
Silicate antibodies in women with silicone breast implants: development of an assay for detection of humoral immunity.
1996 Mar
Activation of MAPKs in human bronchial epithelial cells exposed to metals.
1998 Sep
Thirteen-week subchronic rat inhalation toxicity study with a recovery phase of trivalent chromium compounds, chromic oxide, and basic chromium sulfate.
1999 Dec
Status of antioxidant defense system in chromium-induced Swiss mice tissues.
2004 Jul
The role of oxidative stress in the modulation of aryl hydrocarbon receptor-regulated genes by As3+, Cd2+, and Cr6+.
2005 Dec 1
Transcriptional activation and posttranscriptional modification of Cyp1a1 by arsenite, cadmium, and chromium.
2007 Aug
Effects of subchronic exposure via drinking water to a mixture of eight water-contaminating metals: a biochemical and histopathological study in male rats.
2007 Nov
Immunosuppressive effect of subchronic exposure to a mixture of eight heavy metals, found as groundwater contaminants in different areas of India, through drinking water in male rats.
2007 Oct
The peripheral quantitative computed tomographic and densitometric analysis of skeletal tissue in male Wistar rats after chromium sulfate treatment.
2017 Sep 21
Patents

Patents

Substance Class Chemical
Created
by admin
on Sat Dec 16 05:42:57 GMT 2023
Edited
by admin
on Sat Dec 16 05:42:57 GMT 2023
Record UNII
V236ZVR3RL
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
CHROMIUM GLUCONATE
Common Name English
D-GLUCONIC ACID, CHROMIUM SALT
Common Name English
CHROMIUM(III) GLUCONATE
Common Name English
Code System Code Type Description
DAILYMED
V236ZVR3RL
Created by admin on Sat Dec 16 05:42:57 GMT 2023 , Edited by admin on Sat Dec 16 05:42:57 GMT 2023
PRIMARY
RXCUI
1311292
Created by admin on Sat Dec 16 05:42:57 GMT 2023 , Edited by admin on Sat Dec 16 05:42:57 GMT 2023
PRIMARY RxNorm
PUBCHEM
71587119
Created by admin on Sat Dec 16 05:42:57 GMT 2023 , Edited by admin on Sat Dec 16 05:42:57 GMT 2023
PRIMARY
CAS
33661-40-4
Created by admin on Sat Dec 16 05:42:57 GMT 2023 , Edited by admin on Sat Dec 16 05:42:57 GMT 2023
PRIMARY
FDA UNII
V236ZVR3RL
Created by admin on Sat Dec 16 05:42:57 GMT 2023 , Edited by admin on Sat Dec 16 05:42:57 GMT 2023
PRIMARY
DRUG BANK
DB14528
Created by admin on Sat Dec 16 05:42:57 GMT 2023 , Edited by admin on Sat Dec 16 05:42:57 GMT 2023
PRIMARY
EPA CompTox
DTXSID20187342
Created by admin on Sat Dec 16 05:42:57 GMT 2023 , Edited by admin on Sat Dec 16 05:42:57 GMT 2023
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY